Incorporating Polygenic Risk Scores and Nongenetic Risk Factors for Breast Cancer Risk Prediction among Asian Women, Results from Asia Breast Cancer Consortium
Incorporating Polygenic Risk Scores and Nongenetic Risk Factors for Breast Cancer Risk Prediction among Asian Women, Results from Asia Breast Cancer Consortium
Abstract ImportancePolygenic risk scores (PRSs) have shown promises in breast cancer risk prediction; however, limited studies have been conducted among Asian women. ObjectiveTo develop breast cancer risk prediction models for Asian women incorporating PRSs and nongenetic risk factors. DesignPRSs were developed using data from genome-wide association studies (GWAS) of breast cancer conducted among 123 041 Asian-ancestry women (including 18 650 cases) using three approaches (1) reported PRS for European-ancestry women; (2) breast cancer-associated single-nucleotide polymorphisms (SNPs) identified by fine-mapping of GWAS-identified risk loci; (3) genome-wide risk prediction algorithms. A nongenetic risk score (NgRS) was built including six well-established nongenetic risk factors using data from 1974 Asian women. Integrated risk scores (IRSs) were constructed using PRSs and the NgRS. PRSs were initially validated in an independent dataset including 1426 cases and 1323 controls and further evaluated, along with the NgRS and IRSs, in the second dataset including 368 cases and 736 controls nested withing a prospective cohort study. SettingCase-control and prospective cohort studies. Participants20 444 breast cancer cases and 106 450 controls from the Asia Breast Cancer Consortium. Main Outcomes and MeasuresLogistic regression was used to examine associations of risk scores with breast cancer risk to estimate odds ratios (ORs) with 95% confidence intervals (CIs) and area under the receiver operating characteristic curve (AUC). ResultsIn the prospective cohort, PRS111, a PRS with 111 SNPs, developed using the fine-mapping approach showed a prediction performance comparable to a genome-wide PRS including over 855,000 SNPs. The OR per standard deviation increase of PRS111 was 1.67 (95% CI=1.46-1.92) with an AUC of 0.639 (95% CI=0.604-0.674). The NgRS had a limited predictive ability (AUC=0.565; 95% CI=0.529-0.601); while IRS111, the combination of PRS111 and NgRS, achieved the highest prediction accuracy (AUC=0.650; 95% CI=0.616-0.685). Compared with the average risk group (40th-60th percentile), women in the top 5% of PRS111 and IRS111 were at a 3.84-folded (95% CI=2.30-6.46) and 4.25-folded (95% CI=2.57-7.11) elevated risk of breast cancer, respectively. Conclusions and RelevancePRSs derived using breast cancer-associated risk SNPs have similar prediction performance in Asian and European descendants. Including nongenetic risk factors in models further improved prediction accuracy. Our findings support the utility of these models in developing personalized screening and prevention strategies. Key PointsQuestionWhat is the performance of breast cancer risk prediction models for Asian women incorporating polygenic risk scores (PRSs) and nongenetic risk factors?FindingsA 111-genetic-variant PRS developed using data of 125 790 Asian women was significantly associated with breast cancer risk in an independent case-control study nested within a prospective cohort, with an odd ratio (OR) per standard deviation increase of 1.67 (95% confidence interval [CI]=1.46-1.92) and an area under the receiver operating characteristic curve (AUC) of 0.639 (95% CI=0.604-0.674). The prediction model including this PRS and six nongenetic risk factors improved the AUC to 0.650 (95% CI=0.616-0.685).MeaningOur study provides strong supports for the utility of prediction models in identifying Asian women at high risk of breast cancer.
Jia Guochong、Yang Yaohua、Cai Qiuyin、Gu Kai、Zheng Ying、Choi Ji-Yeob、Shu Xiang、Park Min Ho、Kong Sun-Young、Kweon Sun-Seog、Kang Daehee、Gao Yu-Tang、Li Bingshan、Lee Eun-Sook、Tao Ran、Wen Wanqing、Shu Xiao-Ou、Long Jirong、Park Boyoung、Shin Min-Ho、Zheng Wei
Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical CenterDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical CenterDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical CenterShanghai Municipal Center for Disease Control and Prevention, Shanghai Institutes of Preventive MedicineDepartment of Cancer Prevention, Fudan University Shanghai Cancer CenterDepartment of Biomedical Sciences, Seoul National University College of Medicine||Department of Preventive Medicine, Seoul National University College of Medicine||Cancer Research Institute, Seoul National University College of MedicineDepartment of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer CenterDepartment of Surgery, Chonnam National University Medical School & HospitalNational Cancer Center Graduate School of Cancer Science and Policy||Hospital, National Cancer Center||Research Institute, National Cancer CenterDepartment of Preventive Medicine, Chonnam National University Medical School||Jeonnam Regional Cancer Center, Chonnam National University Hwasun HospitalDepartment of Preventive Medicine, Seoul National University College of Medicine||Cancer Research Institute, Seoul National University College of Medicine||Department of Biomedical Sciences, Seoul National University Graduate School||Institute of Environmental Medicine, Seoul National University Medical Research CenterState Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of MedicineDepartment of Molecular Physiology & Biophysics, Vanderbilt Genetics Institute, Vanderbilt UniversityNational Cancer Center Graduate School of Cancer Science and Policy||Hospital, National Cancer Center||Research Institute, National Cancer CenterDepartment of Biostatistics, Vanderbilt University Medical CenterDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical CenterDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical CenterDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical CenterResearch Institute, National Cancer Center||Department of Preventive Medicine, Hanyang University College of MedicineDepartment of Preventive Medicine, Chonnam National University Medical SchoolDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
肿瘤学预防医学医学研究方法
Jia Guochong,Yang Yaohua,Cai Qiuyin,Gu Kai,Zheng Ying,Choi Ji-Yeob,Shu Xiang,Park Min Ho,Kong Sun-Young,Kweon Sun-Seog,Kang Daehee,Gao Yu-Tang,Li Bingshan,Lee Eun-Sook,Tao Ran,Wen Wanqing,Shu Xiao-Ou,Long Jirong,Park Boyoung,Shin Min-Ho,Zheng Wei.Incorporating Polygenic Risk Scores and Nongenetic Risk Factors for Breast Cancer Risk Prediction among Asian Women, Results from Asia Breast Cancer Consortium[EB/OL].(2025-03-28)[2025-06-13].https://www.medrxiv.org/content/10.1101/2021.09.23.21263888.点此复制
评论